Wegovy Study Bolsters Use In Patients With Obesity and Heart Disease
Novo Nordisk A/S unveiled details from a closely watched study that support use of Wegovy, its blockbuster weight-loss
2023-11-11 21:49
Weight-Loss Drugs Among the Most Sought-After New Corporate Benefits
The craze around pricey weight-loss drugs has many people clamoring for these treatments in company-sponsored health plans. While
2023-11-11 00:47
Novo to Build $6 Billion Plant as Obesity Drug Demand Surges
Novo Nordisk A/S will invest more than 42 billion kroner ($6 billion) to expand its manufacturing facilities as
2023-11-10 21:25
Drugmaker Novo Nordisk seeks obesity, diabetes 'bolt-on' deals
By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN Novo Nordisk wants to buy more companies with drugs in early-
2023-11-10 19:20
Weight-loss drug maker Novo Nordisk invests $6 billion to boost output
COPENHAGEN Novo Nordisk said on Friday it will invest more than 42 billion crowns ($6 billion) in its
2023-11-10 17:27
Astra Enters Obesity Drug Race With Chinese Biotech Deal
AstraZeneca Plc clinched a deal to develop a drug from the pharma industry’s hottest class of medicines, agreeing
2023-11-09 18:54
New Ozempic Rival Is About to Make Your Weight Loss Drugs Cheaper
An effective and massively popular weight-loss drug has made Novo Nordisk A/S billions of dollars and turned it
2023-11-09 07:22
Eli Lilly Wins FDA Nod for Obesity Drug That Rivals Wegovy, Ozempic
Eli Lilly & Co. won US approval for its diabetes drug to treat obesity, unlocking blockbuster sales potential
2023-11-09 04:27
European Stocks On Track for Best Run Since July on Fed Optimism
European shares advanced for a fourth day, set for their longest winning streak since July, fueled by hopes
2023-11-02 18:52
Novo Nordisk’s Earnings Surge on Frenzy for Obesity Drugs
Novo Nordisk A/S sales surged in the third quarter as demand continued unabated for its obesity and diabetes
2023-11-02 16:26
Novo Nordisk flags continued restrictions on Wegovy supplies
COPENHAGEN (Reuters) -Novo Nordisk on Thursday reported record sales and operating profits for the third quarter but flagged continued restrictions
2023-11-02 14:55
When Japan Ends Negative Rate Policy, Treasuries Will Suffer
Japan’s era of negative interest rates will end in coming months, and the implications for world markets will
2023-10-23 08:52